Jaffee EM - Search Results

1

Cancer immunoprevention--the next frontier.

Smit MA, Jaffee EM, Lutz ER. Smit MA, et al. Among authors: jaffee em. Cancer Prev Res (Phila). 2014 Nov;7(11):1072-80. doi: 10.1158/1940-6207.CAPR-14-0178. Epub 2014 Sep 22. Cancer Prev Res (Phila). 2014. PMID: 25245763 Free PMC article. Review.

2

Cancer vaccines.

Greten TF, Jaffee EM. Greten TF, et al. Among authors: jaffee em. J Clin Oncol. 1999 Mar;17(3):1047-60. doi: 10.1200/JCO.1999.17.3.1047. J Clin Oncol. 1999. PMID: 10071300 Review.

3

Immunotherapy of cancer.

Jaffee EM. Jaffee EM. Ann N Y Acad Sci. 1999;886:67-72. doi: 10.1111/j.1749-6632.1999.tb09401.x. Ann N Y Acad Sci. 1999. PMID: 10667204 Review.

4

HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice.

Reilly RT, Gottlieb MB, Ercolini AM, Machiels JP, Kane CE, Okoye FI, Muller WJ, Dixon KH, Jaffee EM. Reilly RT, et al. Among authors: jaffee em. Cancer Res. 2000 Jul 1;60(13):3569-76. Cancer Res. 2000. PMID: 10910070

5

The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.

Reilly RT, Machiels JP, Emens LA, Ercolini AM, Okoye FI, Lei RY, Weintraub D, Jaffee EM. Reilly RT, et al. Among authors: jaffee em. Cancer Res. 2001 Feb 1;61(3):880-3. Cancer Res. 2001. PMID: 11221874

6

Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.

Machiels JP, Reilly RT, Emens LA, Ercolini AM, Lei RY, Weintraub D, Okoye FI, Jaffee EM. Machiels JP, et al. Among authors: jaffee em. Cancer Res. 2001 May 1;61(9):3689-97. Cancer Res. 2001. PMID: 11325840

7

Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.

Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SR, Leach SD, Ryu B, Skinner HG, Goggins M, Jaffee EM, Yeo CJ, Cameron JL, Kern SE, Hruban RH. Argani P, et al. Among authors: jaffee em. Cancer Res. 2001 Jun 1;61(11):4320-4. Cancer Res. 2001. PMID: 11389052

8

Immunologic approaches to the management of pancreatic cancer.

Laheru D, Biedrzycki B, Jaffee EM. Laheru D, et al. Among authors: jaffee em. Cancer J. 2001 Jul-Aug;7(4):324-37. Cancer J. 2001. PMID: 11561608 Review.

9

HER-2/neu-specific monoclonal antibodies collaborate with HER-2/neu-targeted granulocyte macrophage colony-stimulating factor secreting whole cell vaccination to augment CD8+ T cell effector function and tumor-free survival in Her-2/neu-transgenic mice.

Wolpoe ME, Lutz ER, Ercolini AM, Murata S, Ivie SE, Garrett ES, Emens LA, Jaffee EM, Reilly RT. Wolpoe ME, et al. Among authors: jaffee em. J Immunol. 2003 Aug 15;171(4):2161-9. doi: 10.4049/jimmunol.171.4.2161. J Immunol. 2003. PMID: 12902523

10

Cancer vaccines: an old idea comes of age.

Emens LA, Jaffee EM. Emens LA, et al. Among authors: jaffee em. Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S161-8. Cancer Biol Ther. 2003. PMID: 14508095 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

326 results

Search Page